Skip to main content
Erschienen in: Annals of Surgical Oncology 3/2010

01.10.2010 | American Society of Breast Surgeons

Impact of Preoperative Breast MRIs on Timing of Surgery and Type of Intervention in Newly Diagnosed Breast Cancer Patients

verfasst von: Fernando A. Angarita, MD, Sergio A. Acuna, MD, Adriana Fonseca, MD, Pavel Crystal, MD, Jaime Escallon, MD, FRCS(C), FACS

Erschienen in: Annals of Surgical Oncology | Sonderheft 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

We sought to evaluate the effect of preoperative breast magnetic resonance imaging (BMRI) on the wait time to surgery and to what extent it affects the surgical management plan initially considered.

Methods

From April 2007 to April 2009, a total of 147 newly diagnosed breast cancer patients who underwent surgery as initial treatment at Marvelle Koffler Breast Centre at Mount Sinai Hospital, Toronto, Ontario, Canada, met the inclusion criteria and were divided into two groups: those who had BMRI (n = 71) and those who did not (n = 76). Time to surgery was calculated from the day core biopsy result was available to the date surgery was carried out. Time span between initial surgical consult and the day of the surgery day was also calculated. Change was defined as conversion from conservative to radical surgery and/or unilateral to bilateral procedures.

Results

Overall waiting period between histologic diagnosis and treatment was 34.2 days (BMRI group 36.0 days vs. non-BMRI group 32.3 days, P = 0.15); and between date surgical management was propose and date of surgery (BMRI group 24.2 days vs. non-BMRI group 22.5 days, P = 0.38). Additional workup resulted in seven otherwise occult malignant lesions that required change. Ten percent of patients who underwent BMRI had change in surgical management. The mastectomy rate was higher among those with preoperative BMRI (initial 12% vs. final 26%, P = 0.8), but this was not statistically significant.

Conclusions

Preoperative BMRI did not delay surgical treatment or correlate with a higher rate of radical treatment.
Literatur
1.
Zurück zum Zitat Dummin LJ, Cox M, Plant L. Prediction of breast tumor size by mammography and sonography—a breast screen experience. Breast. 2007;16:38–46.CrossRefPubMed Dummin LJ, Cox M, Plant L. Prediction of breast tumor size by mammography and sonography—a breast screen experience. Breast. 2007;16:38–46.CrossRefPubMed
2.
Zurück zum Zitat Heusinger K, Lohberg C, Lux MP, et al. Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself. Breast Cancer Res Treat. 2005;94:17–23.CrossRefPubMed Heusinger K, Lohberg C, Lux MP, et al. Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself. Breast Cancer Res Treat. 2005;94:17–23.CrossRefPubMed
3.
Zurück zum Zitat Lagios MD, Westdahl PR, Rose MR. The concept and implications of multicentricity in breast carcinoma. Pathol annu. 1981;16(Pt 2):83–102.PubMed Lagios MD, Westdahl PR, Rose MR. The concept and implications of multicentricity in breast carcinoma. Pathol annu. 1981;16(Pt 2):83–102.PubMed
4.
Zurück zum Zitat Holland R, Veling SHJ, Mravunc M, et al. Histologic multifocality of Tis, T1–2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer. 1985:56:979–90.CrossRefPubMed Holland R, Veling SHJ, Mravunc M, et al. Histologic multifocality of Tis, T1–2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer. 1985:56:979–90.CrossRefPubMed
5.
Zurück zum Zitat Vaidya JS, Vyas JJ, Chinoy RF, et al. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer. 1996;74:820–4.PubMed Vaidya JS, Vyas JJ, Chinoy RF, et al. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer. 1996;74:820–4.PubMed
6.
Zurück zum Zitat Kurtz JM, Jacquemier J, Amatric R, et al. Breast conserving therapy for macroscopically multiple cancer. Ann Surg. 1990;212:38–44.CrossRefPubMed Kurtz JM, Jacquemier J, Amatric R, et al. Breast conserving therapy for macroscopically multiple cancer. Ann Surg. 1990;212:38–44.CrossRefPubMed
7.
Zurück zum Zitat Wilson LD, Beinfield M, McKhan CF, et al. Conservative surgery and radiation in treatment of synchronous ipsilateral breast cancers. Cancer. 1993 72:137–42.CrossRefPubMed Wilson LD, Beinfield M, McKhan CF, et al. Conservative surgery and radiation in treatment of synchronous ipsilateral breast cancers. Cancer. 1993 72:137–42.CrossRefPubMed
8.
Zurück zum Zitat Esserman L, Hylton N, Yassa L, et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol. 1999;17:110–9.PubMed Esserman L, Hylton N, Yassa L, et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol. 1999;17:110–9.PubMed
9.
Zurück zum Zitat Fischer U, Zachariae O, Baum F, et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol. 2004;14:1725–31.PubMed Fischer U, Zachariae O, Baum F, et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol. 2004;14:1725–31.PubMed
10.
Zurück zum Zitat Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the wholebreast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183:1149–57.PubMed Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the wholebreast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183:1149–57.PubMed
11.
Zurück zum Zitat Deurloo E, Deterse JL, Rutgers E, et al. Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerized analysis. Eur J Cancer. 2005;41:1393–401.CrossRefPubMed Deurloo E, Deterse JL, Rutgers E, et al. Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerized analysis. Eur J Cancer. 2005;41:1393–401.CrossRefPubMed
12.
Zurück zum Zitat Fischer U, Baum F, Luftner-Nagel S. Preoperative MR imaging in patients with breast cancer: preoperative staging, effects on recurrence rates, and outcome analysis. Magn Reson Imaging Clin N Am. 2006;14:351–62.CrossRefPubMed Fischer U, Baum F, Luftner-Nagel S. Preoperative MR imaging in patients with breast cancer: preoperative staging, effects on recurrence rates, and outcome analysis. Magn Reson Imaging Clin N Am. 2006;14:351–62.CrossRefPubMed
13.
Zurück zum Zitat Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295–303.CrossRefPubMed Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295–303.CrossRefPubMed
14.
Zurück zum Zitat Van Goethem M, Schelfout K, Dijckmans L, et al. MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol. 2004;14:809–16.CrossRefPubMed Van Goethem M, Schelfout K, Dijckmans L, et al. MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol. 2004;14:809–16.CrossRefPubMed
15.
Zurück zum Zitat Tozaki M, Fukuma E, Kawano N, et al. Bilateral breast MR imaging: is it superior to conventional methods for the detection of contralateral breast cancer? Breast Cancer. 2008;15:169–74.CrossRefPubMed Tozaki M, Fukuma E, Kawano N, et al. Bilateral breast MR imaging: is it superior to conventional methods for the detection of contralateral breast cancer? Breast Cancer. 2008;15:169–74.CrossRefPubMed
16.
Zurück zum Zitat Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26:3248–58.CrossRefPubMed Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26:3248–58.CrossRefPubMed
17.
Zurück zum Zitat Liberman L, Morris EA, Kim CM, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenl. 2003;180:333–41. Liberman L, Morris EA, Kim CM, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenl. 2003;180:333–41.
18.
Zurück zum Zitat Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology. 2003;226:773–8.CrossRefPubMed Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology. 2003;226:773–8.CrossRefPubMed
20.
Zurück zum Zitat Bevers TB, Anderson BO, Bonaccio E, et al. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw. 2009;7:1060–96.PubMed Bevers TB, Anderson BO, Bonaccio E, et al. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw. 2009;7:1060–96.PubMed
21.
Zurück zum Zitat Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209:180–7.CrossRefPubMed Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209:180–7.CrossRefPubMed
24.
Zurück zum Zitat Lehman CD, DeMartini W, Anderson BO, et al. Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Canc Netw. 2009;792:193–201. Lehman CD, DeMartini W, Anderson BO, et al. Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Canc Netw. 2009;792:193–201.
25.
Zurück zum Zitat Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrastenhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology. 1997;203:137–44.PubMed Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrastenhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology. 1997;203:137–44.PubMed
26.
Zurück zum Zitat Muller-Schimpfle M, Ohmenhauser K, Stoll P, et al. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology. 1997;203:145–9.PubMed Muller-Schimpfle M, Ohmenhauser K, Stoll P, et al. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology. 1997;203:145–9.PubMed
27.
Zurück zum Zitat Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98:468–73.CrossRefPubMed Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98:468–73.CrossRefPubMed
28.
Zurück zum Zitat Sardanelli F. Overview of the role of pre-operative breast MRI in the absence of evidence on patient outcomes. Breast. 2010 Feb;19:3–6.CrossRefPubMed Sardanelli F. Overview of the role of pre-operative breast MRI in the absence of evidence on patient outcomes. Breast. 2010 Feb;19:3–6.CrossRefPubMed
29.
Zurück zum Zitat Krishnan M, Thorsteinsson D, Horowitz N, et al. The influence of preoperative MRI in the timing and type of therapy in women newly diagnosed with breast cancer. AJR Am J Roentgenol. 2008;190:A31–4. Krishnan M, Thorsteinsson D, Horowitz N, et al. The influence of preoperative MRI in the timing and type of therapy in women newly diagnosed with breast cancer. AJR Am J Roentgenol. 2008;190:A31–4.
31.
Zurück zum Zitat Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119–26.CrossRefPubMed Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119–26.CrossRefPubMed
32.
Zurück zum Zitat Colbert K. The longer the delay, the greater the anxiety. Delay in treatment for breast cancer. Prof Nurse. 1994;9:517–20.PubMed Colbert K. The longer the delay, the greater the anxiety. Delay in treatment for breast cancer. Prof Nurse. 1994;9:517–20.PubMed
33.
Zurück zum Zitat Hollingsworth AB, Stough RG. Preoperative breast MRI for locoregional staging. J Okla State Med Assoc. 2006;99:505–15.PubMed Hollingsworth AB, Stough RG. Preoperative breast MRI for locoregional staging. J Okla State Med Assoc. 2006;99:505–15.PubMed
34.
Zurück zum Zitat Schnall MD, Blume J, Bluemke DA, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol. 2005;92:32–8.CrossRefPubMed Schnall MD, Blume J, Bluemke DA, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol. 2005;92:32–8.CrossRefPubMed
35.
Zurück zum Zitat Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology. 1999;213:881–8.PubMed Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology. 1999;213:881–8.PubMed
36.
Zurück zum Zitat Lehman CD, Blume JD, Thickman D, et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol. 2005;92:9–15.CrossRefPubMed Lehman CD, Blume JD, Thickman D, et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol. 2005;92:9–15.CrossRefPubMed
37.
Zurück zum Zitat Morrow M. Magnetic resonance imaging in the preoperative evaluation of breast cancer: primum non nocere. J Am Coll Surg. 2004;198:240–1.CrossRefPubMed Morrow M. Magnetic resonance imaging in the preoperative evaluation of breast cancer: primum non nocere. J Am Coll Surg. 2004;198:240–1.CrossRefPubMed
38.
Zurück zum Zitat Turnbull L, Brown S, Harvey I, et al. Comparative Effectiveness of MRI in Breast Cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010;375:528–30.CrossRef Turnbull L, Brown S, Harvey I, et al. Comparative Effectiveness of MRI in Breast Cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010;375:528–30.CrossRef
39.
Zurück zum Zitat Clemons M, Danson S, Hamilton T, et al. Locoregionally recurrent breast cancer: incidence, risk factors and survival. Cancer Treat Rev. 2001;27:67–82.CrossRefPubMed Clemons M, Danson S, Hamilton T, et al. Locoregionally recurrent breast cancer: incidence, risk factors and survival. Cancer Treat Rev. 2001;27:67–82.CrossRefPubMed
40.
Zurück zum Zitat Punglia R, Morrow M, Winer E, et al. Local therapy and survival in breast cancer. N Engl J Med. 2007;356:2399–405.CrossRefPubMed Punglia R, Morrow M, Winer E, et al. Local therapy and survival in breast cancer. N Engl J Med. 2007;356:2399–405.CrossRefPubMed
41.
Zurück zum Zitat Liberman L, Morris EA, Dershaw DD, et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol. 2003;180:901–10.PubMed Liberman L, Morris EA, Dershaw DD, et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol. 2003;180:901–10.PubMed
42.
Zurück zum Zitat Lim HI, Choi JH, Yan JH, et al. Does pre-operative breast magnetic resonance imaging in addition to mammography and breast ultrasonography change the operative management of breast carcinoma? Breast Cancer Res Treat. 2010;119:163–7.CrossRefPubMed Lim HI, Choi JH, Yan JH, et al. Does pre-operative breast magnetic resonance imaging in addition to mammography and breast ultrasonography change the operative management of breast carcinoma? Breast Cancer Res Treat. 2010;119:163–7.CrossRefPubMed
43.
Zurück zum Zitat Bilimoria KY, Cambic A, Hansen NM, et al. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg. 2007;142:441–5.CrossRefPubMed Bilimoria KY, Cambic A, Hansen NM, et al. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg. 2007;142:441–5.CrossRefPubMed
44.
Zurück zum Zitat Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, linical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830–49.CrossRefPubMed Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, linical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830–49.CrossRefPubMed
45.
Zurück zum Zitat Bagley FH. The role of magnetic resonance imaging mammography in the surgical management of the index breast cancer. Arch Surg. 2004;139:380–3.CrossRefPubMed Bagley FH. The role of magnetic resonance imaging mammography in the surgical management of the index breast cancer. Arch Surg. 2004;139:380–3.CrossRefPubMed
46.
Zurück zum Zitat Zhang Y, Fukatsu H, Naganawa S, et al. The role of contrast-enhanced MR mammography for determining candidates for breast conservation surgery. Breast Cancer. 2002;9:231–9.CrossRefPubMed Zhang Y, Fukatsu H, Naganawa S, et al. The role of contrast-enhanced MR mammography for determining candidates for breast conservation surgery. Breast Cancer. 2002;9:231–9.CrossRefPubMed
47.
Zurück zum Zitat Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology. 1995;196:115–22.PubMed Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology. 1995;196:115–22.PubMed
Metadaten
Titel
Impact of Preoperative Breast MRIs on Timing of Surgery and Type of Intervention in Newly Diagnosed Breast Cancer Patients
verfasst von
Fernando A. Angarita, MD
Sergio A. Acuna, MD
Adriana Fonseca, MD
Pavel Crystal, MD
Jaime Escallon, MD, FRCS(C), FACS
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe Sonderheft 3/2010
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1239-1

Weitere Artikel der Sonderheft 3/2010

Annals of Surgical Oncology 3/2010 Zur Ausgabe

American Society of Breast Surgeons

Pure Tubular Carcinoma and Axillary Nodal Metastases

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.